Abstract
Cytogenetic information in patients with myelodysplastic syndrome (MDS) is important in predicting prognosis and therapeutic direction. In MDS, the detection of numerical type abnormalities, either whole chromosome or partial chromosomal segments, is important. In general, conventional banding chromosome analysis is useful in detecting chromosome changes in MDS and is able to predict prognosis. More recently, uniparental disomy at various loci has been found in some MDS patients and target genes located within the deleted chromosome regions; these deletions are either cytogenetically detectable resulting in partial monosomy, or cryptic. Further therapeutic approaches for MDS patients may require more precise cytogenetic information in the near future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brunning, R.D., Bennett, J.M., Flandrin, G., Matutes, E., Head, D., Vardiman, J.W., and Harris, N.L. (2001) Myelodysplastic syndromes. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (Eds. Jaffe, E.S., Harris, N.L., Stein, H., and Vardiman, J.W.), pp 61–73, IARC Press: Lyon.
Brunning, R.D., Orazi, A., Germing, U., Le Beau, M.M., Porwit, A., Bauman, I., Vardiman, J.W., and Hellstrom-Lindberg, E. (2008) Myelodysplastic syndromes. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Eds. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W.), pp 87–107, IARC Press: Lyon.
Olney, H.J. and Le Beau, M.M. (2007) Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes. Leuk Res 31,427–34.
Haase, D. (2008) Cytogenetic features in myelodysplastic syndromes. Ann Hematol 87, 515–26.
Bernasconi, P., Boni, M., Cavigliano, P.M., Calatroni, S., Giardini, I., Rocca, B., Zappatore, R., Dambruoso, I., and Caresana, M. (2006) Clinical relevance of cytogenetics in myelodysplastic syndromes. Ann NY Acad Sci 1089, 395–410.
Panani, A.D. and Roussos, C. (2006) Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implicationsÂ. Cancer Lett 235, 177–90.
Steensma, D.P. and List, A.F. (2005) Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc 80, 681–98.
Nimer, S.D. (2006) Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q. J Clin Oncol 24, 2576–82.
Campbell, L.J. and Garson, O.M. (1994) The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia 8, 67–71.
Van den Berghe, H., Cassiman, J.J., David, G., Fryns, J.P., Michaux, J.L., and Sokal, G (1974) Distinct haematological disorder with deletion of the long arm of no. 5 chromosome. Nature 251, 437.
Boultwood, J., Lewis, S., and Wainscoat, J.S. (1994) The 5q-syndrome. Blood 84, 3253–60.
Liu, T.X., Becker, M.W., Jelinek, J., Wu, W.S., Deng, M., Mikhalkevich, N., Hsu, K., Bloomfield, C.D., Stone, R.M., DeAngelo, D.J., Galinsky, I.A., Issa, J.P., Clarke, M.F., and Look, A.T. (2007) Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nat Med 13, 78–83.
Joslin, J.M., Fernald, A.A., Tennant, T.R., Davis, E.M., Kogan, S.C., Anastasi, J., Crispino, J.D., and Le Beau, M.M. (2007) Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 110, 719–26.
Zou, Y.S., Fink, S.R., Stockero, K.J., Paternoster, S.F., Smoley, S.A., Tun, H.W., Reeder, C.B., Tefferi, A., and Dewald, D.W. (2007) Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide. Leuk Res 31, 1185–9
Gondek, L.P., Haddad, A.S., O’Keefe, C.L., Tiu, R., Wlodarski, M.W., Sekeres, M.A., Theil, K.S., and Maciejewski, J.P. (2007) Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes. Exp Hematol 35, 1728–38.
Gondek, L.P., Tiu, R., O’Keefe, C.L., Sekeres, M.A., Theil, K.S., and Maciejewski, J.P. (2008) Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 111, 1534–42.
Toyama, K., Ohyashiki, K., Yoshida, Y., Abe, T., Asano, S., Hirai, H., Hirashima, K., Hotta, T., Kuramoto, A., Kuriya, S., et al. (1993) Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 7, 499–508.
Morel, P., Hebbar, M., Lai, J.L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F., and Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 7, 1315–23.
Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G., and Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89, 2079–88.
Malcovati, L., Porta, M.G., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., Lazzarino, M., and Cazzola, M. (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 23, 7594–603.
Slovak, M.L. and Dewald, G.W. (2008) International Working Group on MDS cytogenetics: October 2007 meeting report. Leuk Res 32, 1329–32.
Acknowledgements
The authors are indebted to Prof. J. Patrick Barron of the Department of International Medical Communications of Tokyo Medical University for his review of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ohyashiki, K., Kodama, A., Ohyashiki, J.H. (2011). Cytogenetics in Myelodysplastic Syndromes. In: Campbell, L. (eds) Cancer Cytogenetics. Methods in Molecular Biology, vol 730. Humana Press. https://doi.org/10.1007/978-1-61779-074-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-61779-074-4_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-073-7
Online ISBN: 978-1-61779-074-4
eBook Packages: Springer Protocols